Orange backs French pharma automation startup

What's the deal? Orange has invested in a French startup that builds tools to speed the development of pharmaceuticals and life sciences products. The deal was announced in September 2026.

What's the endgame? The startup focuses on automation mechanisms designed to accelerate how drugs and life sciences products are developed.

The signal: The move continues Orange's pattern of backing French technology, extending the telecoms group's reach into pharma automation.

Read more: mobileworldlive.com

Image credit: U.S. Army Combat Capabilities Development Command